Pharmacogenetics of beta-blockers (Q24644448)

Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment

Europe PubMed Central

title

Pharmacogenetics of beta-blockers (English)

0 references

author name string

Jaekyu Shin

series ordinal

1

0 references

Julie A Johnson

series ordinal

2

0 references

language of work or name

English

0 references

publication date

June 2007

0 references

published in

Pharmacotherapy

0 references

volume

27

0 references

issue

6

0 references

page(s)

874-87

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Cardiovascular drug class specificity: beta-blockers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Drug-drug interactions of beta-adrenoceptor blockers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

The beta-adrenergic blocking agents and the treatment of glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Aten

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

beta2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

30 May 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Angiotensinogen gene M235T polymorphism and reduction in wall thickness in response to antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Medical Management of Glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

Polymorphism of the beta-2 adrenoceptor and IOP lowering potency of topical timolol in healthy subjects.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735790

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

28 November 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

21 January 2018

1 reference

12 December 2020

The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure

1 reference

12 December 2020

Association of the G(s)alpha gene with essential hypertension and response to beta-blockade

1 reference

12 December 2020

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome

1 reference

12 December 2020

Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

1 reference

12 December 2020

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

12 December 2020

The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects

1 reference

12 December 2020

The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.6.874

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1592/PHCO.27.6.874

1 reference

1 reference

1 reference

PubMed publication ID

17542770

1 reference